Cigna Group (NYSE:CI) Stock Rating Upgraded by Wall Street Zen

Key Points

• Cigna Group's stock was upgraded from a "hold" to a "buy" rating by Wall Street Zen, with a consensus average target price of $374.76.
• The company reported earnings of $7.20 per share, exceeding estimates and reflecting an 11% increase in revenue year-over-year, totaling $67.13 billion.
• Insider Nicole S. Jones sold 28,526 shares for approximately $8.56 million, reducing her position by over 52%.

Cigna Group (NYSE:CI - Get Free Report) was upgraded by Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Saturday.

Other research analysts have also issued research reports about the stock. Royal Bank Of Canada restated an "outperform" rating and set a $371.00 price target on shares of Cigna Group in a report on Thursday, June 26th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a report on Thursday, August 14th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a "buy" rating in a report on Tuesday, August 5th. Finally, Truist Financial set a $375.00 price target on shares of Cigna Group in a report on Tuesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $374.76.

Cigna Group Stock Down 1.0%

NYSE:CI opened at $302.71 on Friday. The firm's 50 day simple moving average is $295.47 and its 200 day simple moving average is $312.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a one year low of $256.89 and a one year high of $370.83. The company has a market cap of $80.80 billion, a PE ratio of 16.52, a P/E/G ratio of 0.90 and a beta of 0.48.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same quarter last year, the business earned $6.72 EPS. The company's revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.70% of the stock is owned by corporate insiders.

Institutional Trading of Cigna Group

Several hedge funds have recently bought and sold shares of CI. Valeo Financial Advisors LLC grew its position in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider's stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Norges Bank purchased a new position in Cigna Group during the 2nd quarter worth $1,110,426,000. Nuveen LLC bought a new stake in shares of Cigna Group in the 1st quarter worth $727,905,000. GAMMA Investing LLC grew its stake in shares of Cigna Group by 58,799.0% in the 1st quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider's stock worth $583,852,000 after acquiring an additional 1,771,613 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.